In addition, sialylated HMOs suppressed inflammatory cytokine (IL-1β, TNF-α and IL-6) production and reduced NEC incidence and pathological damages in inflamed ileum of NEC rats in vivo [38]. The gene discussed is IL6; the disease is necrotizing enterocolitis.